D. E. Shaw & Co., Inc. Spring Works Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 724,682 shares of SWTX stock, worth $30.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

724,682

Holding current value

$30.3 Million

% of portfolio

0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $1.09 Million - $1.46 Million	-34,030 Reduced 4.49%	724,682 $23.2 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $3.96 Million - $5.23 Million	109,865 Added 16.93%	758,712 $28.6 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $18.9 Million - $27.2 Million	518,535 Added 397.92%	648,847 $31.9 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $465,469 - $915,210	24,576 Added 23.24%	130,312 $4.76 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $1.49 Million - $2.02 Million	-64,311 Reduced 37.82%	105,736 $2.44 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $3.16 Million - $4.46 Million	-136,498 Reduced 44.53%	170,047 $4.46 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $3.01 Million - $4.11 Million	120,625 Added 64.88%	306,545 $7.89 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $875,936 - $1.16 Million	40,310 Added 27.68%	185,920 $4.84 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $2.41 Million - $3.96 Million	-99,853 Reduced 40.68%	145,610 $4.15 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $4.51 Million - $14.7 Million	245,463 New	245,463 $6.04 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $2.73 Million - $3.65 Million	-55,704 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $2.39 Million - $3.39 Million	-44,753 Reduced 44.55%	55,704 $3.45 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $1.59 Million - $2.24 Million	-25,422 Reduced 20.2%	100,457 $6.37 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $1.64 Million - $2.09 Million	-24,362 Reduced 16.22%	125,879 $10.4 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $5.38 Million - $7.74 Million	82,667 Added 122.34%	150,241 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $3.27 Million - $5.27 Million	67,574 New	67,574 $4.9 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.61B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account